MDS Issues MDS US GAAP Primer
25 Janvier 2008 - 2:00PM
PR Newswire (US)
Preparing Investors for MDS' conversion from Canadian to US GAAP
Filing TORONTO, Jan. 25 /PRNewswire-FirstCall/ -- MDS Inc. (TSX:
MDS; NYSE: MDZ), a leading provider of products and services to the
global life sciences markets, today issued an MDS US GAAP Primer in
anticipation of filing its 2007 year-end financials and annual
report for the first time in US GAAP on January 29, 2008. This MDS
US GAAP Primer is intended to prepare investors for MDS' conversion
from Canadian to US GAAP filing. The MDS US GAAP Primer provides an
overview of the relevant differences between US and Canadian GAAP
affecting MDS, including an explanation of the accounting,
presentation and disclosure differences and their impact on MDS
financials. The MDS US GAAP Primer is available on the MDS website
at: http://www.mdsinc.com/. More details including a summary of
significant accounting policies will be available in the notes to
the financial statements in the MDS 2007 Annual Report to be filed
on January 29, 2008. As additional support, MDS also intends to
make available on the MDS website: - 2007 interim financial
statements that have been restated to US GAAP; and, - Canadian to
US GAAP reconciliation tables for MDS and its business units. About
MDS Inc. MDS Inc. is a global life sciences company that provides
market-leading products and services that our customers need for
the development of drugs and the diagnosis and treatment of
disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than
5,500 highly skilled people in 28 countries. Find out more at
http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: Sharon Mathers, Senior
Vice-President, Investor Relations and External Communications, MDS
Inc., (416) 213-4721,
Copyright